Addiction Medicine: Beyond the Abstract

In episode eight of Addiction Medicine: Beyond the Abstract, we are joined by Dr. Lisa Marsch. She is a professor at Dartmouth and Director of both the Center for Technology and Behavioral Health and the Dartmouth Psychiatric Research Center. In her recent study, Marsch and her colleagues took a look at relevant randomized controlled trials and observational studies which evaluated the use of buprenorphine in adolescents and young adults.

To learn more, click here.

In episode 20 of Addiction Medicine: Beyond the Abstract, we are joined by Tami Mark, PhD. She is a Senior Fellow of Behavioral Health Financing and Quality Measurement for RTI International. Dr. Mark discusses patient placement criteria for addiction treatment and multidimensional assessments, which was published in the March/April 2021 issue of Journal of Addiction Medicine. Article: LINK

Addiction Medicine: Beyond the Abstract (Episode 21). Host Shawn McNeil, MD, is joined by Simeon Kimmel, MD, who discusses a trend of referral rejections for post-acute medical care among patients with substance use disorders and patients receiving opioid agonist treatment Dr. Kimmel (@simkimmel) is an Assistant Professor of Medicine at Boston University School of Medicine and Attending Physician at Boston Medical Center.

Journal of Addiction Medicine, January/February 2021, Rejection of Patients With Opioid Use Disorder Referred for Post-acute Medical Care Before and After an Anti-discrimination Settlement in Massachusetts.

In episode two of Addiction Medicine: Beyond the Abstract, we are joined by Dr. Stefan Kertesz of the University of Alabama Birmingham and the Birmingham VA Medical Center. In his recent piece from the Journal, Dr. Kertesz discusses the challenge of treating patients who obtain benzodiazepines from another provider in addition to known prescribed opiates. He addresses this issue in the context of the results from a recent study by McClure, et al. in the same issue of the Journal which analyzes patterns of urine drug test results from a national laboratory.

Read more here.

ASAM developed the Appropriate Use of Drug Testing in Clinical Addiction Medicine document to provide guidance about the effective use of drug testing in the identification, diagnosis, treatment and promotion of recovery for patients with, or at risk for, addiction. Click here.

In episode 28 of Addiction Medicine: Beyond the Abstract, host Shawn McNeil, MD is joined my Ashish Thakrar, MD, MS, an addiction medicine specialist and Assistant Professor of Medicine with the University of Pennsylvania. Dr. Thakrar discusses the outcome of his research, which aimed to determine whether fentanyl concentration is associated with the severity of opioid withdrawal.

Article Link: https://journals.lww.com/journaladdictionmedicine/abstract/2023/07000/association_of_urine_fentanyl_concentration_with.18.aspx

Ashish Thakrar, MD, X (Twitter) Handle: @especially_APT

Journal of Addiction Medicine. 17(4):447-453, July/August 2023.